Cerecin strengthens its leadership position in CNS drug development by adding a biotech veteran to the executive team Bruce Morimoto joins Cerecin as Vice President of Drug Development

Denver, Colorado, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Cerecin, a global healthcare company focused on developing brain health solutions and therapeutics for patients around the world, today announced the appointment of Bruce Morimoto as Vice President of Drug Development.A A Based in the US, Bruce will be responsible for non-clinical drug development and translational medicine for Cerecina??s existing products and future pipeline.Bruce joins Cerecina??s senior executive team with over 20 yearsa?? experience in research and development roles within leading institutions. Most recently, Bruce held the position of Vice President of Drug Development Operations with Alkahest Inc, a biopharmaceutical company targeting neurodegenerative and age-related diseases. In this role he led the organisationa??s clinical operations, project management and manufacturing, helping the company to achieve strategic goals. Prior to his role at Alkahest, he held leadership positions with Celerion, Allon Therapeutics, MDS Pharma Services, and NeuroMed Technologies.A  Bruce also works closely with the Michael J. Fox Foundation as a scientific advisor and is on the advisory board for TIDES.A Bruce has applied his background in chemistry and years of industry experience to therapies related to aging and has published dozens of peer-reviewed papers on topics such as Alzheimera??s and other neurodegenerative diseases.a??Bruce brings a wealth of knowledge that will be extremely valuable to Cerecin. His tremendous experience in senior roles in biotech and at CROs, will be a welcome addition to our leadership team,a?? said Charles Stacey, President and CEO of Cerecin, a??Bruce will be based in the United States where he will continue to grow our presence whilst we leverage his experience to support our global expansion.a??
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2020    »